Lv11
50 积分 2025-03-25 加入
Pan-KRAS destruction with a single PROTAC
10小时前
求助中
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
14小时前
已完结
Targeting KRAS in cancer
4天前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
12天前
已完结
Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies
14天前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
14天前
已完结
New immune cell engagers for cancer immunotherapy
14天前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
15天前
已完结
Novel Treatment Options for Multiple Myeloma
29天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
29天前
已完结
皖公网安备34019202002308
